Searched for
ANTI MALARIA DRUG
For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- Pakistan health authorities seek government permission to import mosquito nets from India after malaria cases surge due to floods: reportThe development came after a deadly malaria onslaught wreaked relentless havoc in flood-affected regions of the country, where hundreds of ...
- Pakistan bans export of anti-malaria drugs amid spike in coronavirus casesThe ban, which has been imposed with immediate effect, will remain till the National Coordination Comm-ittee (NCC) on COVID-19 deems necess...
- After Donald Trump's Hydroxychloroquine clamour Bengal planters hope for surge in quinine demandUS President Donald Trump's strong advocacy of Hydroxychloroquine for treating COVID-19 patients has rekindled hopes of cinchona planters o...
- Gujarat companies to export hydroxychloroquine to US: Vijay RupaniHydroxychloroquine is an old and inexpensive drug used to treat malaria, the export of which was banned by India last month amid views that...
- India partially eases export curbs on Hydroxychloroquine, the anti-malaria drug Donald Trump wantsThe Indian government had earlier put a hold on exports of hydroxychloroquine.
- Serious malaria cases cured by plant therapy in AfricaBengaluru, April 27 (IANS) In a stunningly successful trial, scientists report they cured 18 critically-ill patients suffering from drug-re...
- Effective malaria treatment a step closerThe discovery could potentially make malaria treatment significantly more effective for the 3.2 billion people at risk.
- Australian researchers find new drug to tackle malariaAustralian researchers said that a new drug that stops the malaria parasite from using vitamin B1 to multiply is now plausible.
- India develops a synthetic anti-malaria drug as an alternative ArtemisininIndia has developed a powerful new malaria drug - an alternative to the global drug of choice Artemisinin - that promises to be a major boo...
- Ranbaxy to launch India's first indigenous malaria drug at one-third the cost of current therapiesRanbaxy Laboratories will launch the country’s first indigenously developed new medicine, a malaria drug, at one-third the cost of the curr...
- Drug-resistant malaria may spread, India warnedA new research has warned that drug-resistant malaria parasites on the border of Thailand & Myanmar may spread to India.
- Ranbaxy gets nod for first drug developed by Indian pharma coThe proposed launch could provide a boost to Ranbaxy’s revenues as this combination drug will be cheaper and easier to consume, compared to...
- Ranbaxy starts phase III study of anti-malaria drugRanbaxy Laboratories, India's largest drugmaker by sales, on Monday announced that its new anti-malarial combination drug is now undergoing...
- Ranbaxy launches clinical trials for anti-malaria drugPharma firm Ranbaxy Laboratories on Monday said it has launched clinical trials for its anti-malaria drug Arterolanc maleate Piperaquine ph...
- Ranbaxy set to launch India's first malaria drugDrug major Ranbaxy has successfully completed the phase II clinical trials for the first malaria drug being developed in the country.
- Ranbaxy completes phase II trials for anti-malaria drugRanbaxy has succesfully completed the phase II clinical trials for the first malaria drugs being developed in India since many decades and ...
- Ranbaxy first Indian pharma to launch NCE globallyRanbaxy has completed the second phase of the clinical trial of a revolutionary anti- malarial drug.
- IPCA, CDRI to develop anti-malarial drugs based on ArtemisininIPCA Laboratories and Central Drug Research Institute (CDRI) will develop a synthetic substitute of anti-malarial drugs.
Load More
